GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Other Income (Expense)

Universal Ibogaine (TSXV:IBO) Other Income (Expense) : C$-0.23 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Other Income (Expense)?

Universal Ibogaine's other income expense for the Universal Ibogaine's pretax income for the three months ended in Jan. 2024 was C$0.01 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.23 Mil.

Universal Ibogaine Other Income (Expense) Historical Data

The historical data trend for Universal Ibogaine's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Other Income (Expense) Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Other Income (Expense)
Get a 7-Day Free Trial -0.04 -0.06 -0.21 -5.68 -0.19

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.01 -0.22 - 0.01

Universal Ibogaine Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine  (TSXV:IBO) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Universal Ibogaine (TSXV:IBO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Other Income (Expense)
Comparable Companies
XCNQ:NIRV TSXV:WAVE TSXV:SVS TSXV:VXL TSXV:PSYB XCNQ:CURE XCNQ:CMND TSX:IPCI XCNQ:AGN TSXV:MRVL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IBOGF:USA JC4:Germany
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Website
https://www.universalibogaine.com
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines